Roivant Sciences Ltd (NASDAQ: ROIV) open the trading on Wednesday, with great promise as it jumped 1.71% to $21.98, before settling in for the price of $21.61 at the close. Taking a more long-term approach, ROIV posted a 52-week range of $8.73-$23.47.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -99.51%. Meanwhile, its Annual Earning per share during the time was -99.51%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -365.48%. This publicly-traded company’s shares outstanding now amounts to $689.70 million, simultaneously with a float of $437.45 million. The organization now has a market capitalization sitting at $15.29 billion. At the time of writing, stock’s 50-day Moving Average stood at $20.94, while the 200-day Moving Average is $14.38.
Roivant Sciences Ltd (ROIV) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Roivant Sciences Ltd’s current insider ownership accounts for 37.10%, in contrast to 63.51% institutional ownership. According to the most recent insider trade that took place on Dec 31 ’25, this organization’s President & CIO sold 1,018,995 shares at the rate of 21.71, making the entire transaction reach 22,122,381 in total value, affecting insider ownership by 20,267,429. Preceding that transaction, on Dec 29 ’25, Company’s President & CIO sold 311,873 for 21.74, making the whole transaction’s value amount to 6,780,119. This particular insider is now the holder of 19,273,032 in total.
Roivant Sciences Ltd (ROIV) Earnings and Revenue Records
Roivant Sciences Ltd’s EPS decrease for this current 12-month fiscal period is -365.48% and is forecasted to reach -1.26 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -25.94% through the next 5 years, which can be compared against the -99.51% growth it accomplished over the previous five years trading on the market.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Let’s observe the current performance indicators for Roivant Sciences Ltd (ROIV). It’s Quick Ratio in the last reported quarter now stands at 33.70. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 751.94.
In the same vein, ROIV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.55, a figure that is expected to reach -0.30 in the next quarter, and analysts are predicting that it will be -1.26 at the market close of one year from today.
Technical Analysis of Roivant Sciences Ltd (ROIV)
[Roivant Sciences Ltd, ROIV] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 43.61% While, its Average True Range was 53.90.
Raw Stochastic average of Roivant Sciences Ltd (ROIV) in the period of the previous 100 days is set at 87.51%, which indicates a major rise in contrast to 44.59% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.66 that was higher than 0.57 volatility it exhibited in the past 100-days period.
